Systematic over-expression of secondary metabolism transcription factors to reveal the pharmaceutical potential of Aspergillus nidulans

Many life-saving drugs are derived from fungal secondary metabolites, and the rich diversity of these metabolites is a gold mine of bioactive compounds for drug discovery. However, the biosynthetic genes for most secondary metabolites remain transcriptionally silent in fungi, posing a significant bottleneck in their discovery. Here, we apply a systematic approach to separately over-express 51 secondary metabolism-related transcription factors using the strong inducible promoter of the xylP gene from Penicillium chrysogenum. Growing the individual secondary metabolism transcription factor over-expression strains under inducible conditions leads to the production of a collection of diverse metabolites with anti-bacterial, anti-fungal and anti-cancer activities. The overall approach and the over-expression system established in this study are broadly-applicable, providing a valuable means to revealing the pharmaceutical potentials of fungi.

Authors

Institutions

Publication Details

Journal
Communications Biology
Published
2025-10-09
DOI
https://doi.org/10.1038/s42003-025-08840-z
Citations
1
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systematic over-expression of secondary metabolism transcription factors to reveal the pharmaceutical potential of Aspergillus nidulans

Kaeling Tan, Longguang Qin, Koon Ho Wong, Chi Chiu Mok et al.
1 citations
Communications Biology
Microbial Natural Products and Biosynthesis
1.39
article

Systematic over-expression of secondary metabolism transcription factors to reveal the pharmaceutical potential of Aspergillus nidulans

Kaeling Tan, Longguang Qin, Koon Ho Wong, Chi Chiu Mok, Chirag Parsania, Ben C.B. Ko, Shuhui Guo, Chris Cheung, Lakhansing Pardeshi, Fan Lü, Zhiqiang Dong, Xiaofeng Liu
article en
1 citations

Abstract

Many life-saving drugs are derived from fungal secondary metabolites, and the rich diversity of these metabolites is a gold mine of bioactive compounds for drug discovery. However, the biosynthetic genes for most secondary metabolites remain transcriptionally silent in fungi, posing a significant bottleneck in their discovery. Here, we apply a systematic approach to separately over-express 51 secondary metabolism-related transcription factors using the strong inducible promoter of the xylP gene from Penicillium chrysogenum. Growing the individual secondary metabolism transcription factor over-expression strains under inducible conditions leads to the production of a collection of diverse metabolites with anti-bacterial, anti-fungal and anti-cancer activities. The overall approach and the over-expression system established in this study are broadly-applicable, providing a valuable means to revealing the pharmaceutical potentials of fungi.

Communications BiologyVol. 8(1)
Hong Kong Polytechnic University (HK), University of Macau (MO), Wuxi Taihu Hospital (CN)
United Mitochondrial Disease Foundation, Universidade de Macau, Fundo para o Desenvolvimento das Ciências e da Tecnologia, Faculdade de Ciências da Saúde, Universidade de Macau
Openalex Percentile: Top 15%
Microbial Natural Products and Biosynthesis
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.